Cart
sales@molnova.com
Ridazolol
CAS No. 83395-21-5
Ridazolol( —— )
Catalog No. M34127 CAS No. 83395-21-5
Ridazolol is a vasodilating and cardioselective beta adrenergic blocker.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 445 | Get Quote |
|
| 5MG | 686 | Get Quote |
|
| 10MG | 938 | Get Quote |
|
| 25MG | 1398 | Get Quote |
|
| 50MG | 1822 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameRidazolol
-
NoteResearch use only, not for human use.
-
Brief DescriptionRidazolol is a vasodilating and cardioselective beta adrenergic blocker.
-
DescriptionRidazolol is a vasodilating and cardioselective beta adrenergic blocker.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number83395-21-5
-
Formula Weight373.23
-
Molecular FormulaC15H18Cl2N4O3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESN(CCNCC(COC1=C(Cl)C=CC=C1)O)C2=C(Cl)C(=O)NN=C2
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
PF-03049423 B
PF-03049423 is a potent and highly selective phosphodiesterase-5A inhibitor with an IC50 of approximately 0.2 nM for rat and human thrombomodulin.
-
EED226
EED226 is a potent, selective, and orally bioavailable embryonic ectoderm development (EED) inhibitor with an IC50 of 22 nM.
-
D-Galactosamine HCl
D-Galactosamine HCl?hepatotoxicity is associated with endotoxin sensitivity and mediated by lymphoreticular cells in mice.
